Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -27.41% is 120% below its 5-year average of -12.44%, near the low end of its 5-year range (-27.41%–0.00%).
As of the fiscal period ended Monday, June 30, 2025. 27.70% below its 12-month average of -21.46%.
Annual fiscal-year return on invested capital; no daily interpolation. Historical series through 2025-06-30.
RETURN ON INVESTED CAPITAL (ROIC)
-27.41%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-21.46%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-17.98%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-12.44%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-27.70%
CURRENT VS 3Y AVG
-52.47%
CURRENT VS 5Y AVG
-120.43%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.78%
median of 598 covered companies
CURRENT VS SECTOR MEDIAN
+21.19%
vs the sector median at left
Gelteq Limited Ordinary Shares
Market Cap
$4.96M
Return on Invested Capital (ROIC)
-27.41%
TTM Avg
-21.46%
3Y Avg
-17.98%
5Y Avg
-12.44%
Market Cap
$5.11M
Return on Invested Capital (ROIC)
-126.69%
TTM Avg
-289.57%
3Y Avg
-198.60%
5Y Avg
-147.26%
Market Cap
$5.01M
Return on Invested Capital (ROIC)
-35.07%
TTM Avg
-9.54%
3Y Avg
2.54%
5Y Avg
2.54%
Market Cap
$5.19M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-67.32%
3Y Avg
-73.33%
5Y Avg
-73.33%
Market Cap
$5.20M
Return on Invested Capital (ROIC)
-225.12%
TTM Avg
-13.17%
3Y Avg
-9.09%
5Y Avg
-9.09%
Market Cap
$5.21M
Return on Invested Capital (ROIC)
-179.58%
TTM Avg
-259.96%
3Y Avg
-220.56%
5Y Avg
-170.22%
Market Cap
$5.32M
Return on Invested Capital (ROIC)
-156.69%
TTM Avg
-654.50%
3Y Avg
-599.09%
5Y Avg
-420.09%
Market Cap
$4.83M
Return on Invested Capital (ROIC)
-38.23%
TTM Avg
-122.97%
3Y Avg
-1403.32%
5Y Avg
-860.06%
Market Cap
$4.73M
Return on Invested Capital (ROIC)
-175.26%
TTM Avg
-258.55%
3Y Avg
-208.94%
5Y Avg
-173.09%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gelteq Limited Ordinary Shares (GELS) | $4.96M | -27.41% | -21.46% | -17.98% | -12.44% |
| Imunon, Inc. (IMNN)vs › | $5.11M | -126.69% | -289.57% | -198.60% | -147.26% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.01M | -35.07% | -9.54% | 2.54% | 2.54% |
| Lunai Bioworks Inc. (LNAI)vs › | $5.19M | N/A | -67.32% | -73.33% | -73.33% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.20M | -225.12% | -13.17% | -9.09% | -9.09% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.21M | -179.58% | -259.96% | -220.56% | -170.22% |
| Alzamend Neuro Inc (ALZN)vs › | $5.32M | -156.69% | -654.50% | -599.09% | -420.09% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.83M | -38.23% | -122.97% | -1403.32% | -860.06% |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.73M | -175.26% | -258.55% | -208.94% | -173.09% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.54M | -94.08% | -1223.16% | -731.00% | -532.24% |
ROIC
-27.4%
ROE
-42.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-06-30 | -27.41% |
| 2024-06-30 | -15.52% |
| 2023-06-30 | -14.68% |
| 2022-06-30 | -14.30% |
| 2021-06-30 | -2.70% |
| 2020-06-30 | 0.00% |
